[Treatment outcome for myelodysplastic syndromes (MDS) obtained by the Polish Children's Leukemia/Lymphoma Study Group]

Autor:	A, Chybicka, P, Kołecki, W, Pietras, J, Bogusławska-Jaworska, D, Wójcik, J, Armata, A, Eliasińska, J, Kowalczyk, T, Jackowska, K, Klus, M, Matysiak, A, Krauze, K, Stefańska, R, Rokicka-Milewska, H, Wiśniewska-Slusarz
Rok vydání:	1998
Předmět:	Male Mercaptopurine Valproic Acid Cytarabine Granulocyte-Macrophage Colony-Stimulating Factor Infant Treatment Outcome Child Preschool Myelodysplastic Syndromes Antineoplastic Combined Chemotherapy Protocols Humans Female Child Bone Marrow Transplantation
Zdroj:	Polskie Archiwum Medycyny Wewnetrznej. 99(2)
Popis:	Fourty children with MDS treated in seven centres of The Polish Children's Leukemia Lymphoma Study Group in period 1975-1998y were included to the study. In 16 children RAEB-T, in 2 CMML in 10 RA and in 12 RAEB were diagnosed. Our and literature data showed that BMT is the best therapy for children with MDS. For children, who don't have a donor for BMT. Roacutan therapy seems to be the most effective.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=pmid________::538cfca75cb18e5b3ecb9cfb37c443a7 https://pubmed.ncbi.nlm.nih.gov/9686518 Zobrazit plný text záznamu